Ballicules.com

Etanercept

ENBREL

What it isTNF receptor fusion protein; rheumatoid arthritis, psoriasis and ankylosing spondylitis.

Why this oneA shorter half-life than the antibody TNF blockers, so it clears faster if infection develops.

What limits itIt does NOT work in inflammatory bowel disease, unlike the antibody agents — a common misassumption. Screen for tuberculosis and hepatitis B.

FDA-approved for

FDA label

BOXED WARNING Serious infections (TB, sepsis, invasive fungal, opportunistic) leading to hospitalization/death; lymphoma and other malignancies (some fatal) reported in children/adolescents.
FDA dosingPopulationStartTargetMax
Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitisadult50 mg weekly50 mg weekly50 mg weekly
Plaque psoriasisadult50 mg twice weekly x3 months50 mg weekly50 mg twice weekly (starting)
Plaque psoriasis or juvenile idiopathic arthritispediatric0.8 mg/kg weekly0.8 mg/kg weekly50 mg weekly

Renal Undefined

Hepatic Undefined

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Registry data do not reliably support association with major birth defects; consider risks/benefits.

Lactation Present in low levels in human milk, minimally absorbed by breastfed infant.

⚠ BOXED WARNINGS

Cost, est. cash$1,000–$15,000+/month

Generic entry2029 est. (biosimilar)

Classes and tags

Clinical profile

Therapeutic safety burden3 / 4
Overdose danger2 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4

Legacy pregnancy categoryC

Defining liabilitySerious infection, cytopenias, hepatic injury and malignancy risk require laboratory and clinical monitoring.

Mechanism of action: Etanercept ballicule

Etanercept ballicule: receptor binding, kinetics and half-life diagram

Open Etanercept in the interactive console ↗

Memory aids: mascots and interaction avatars

Etanercept no kinetic interactions avatar
no kinetic interactions

Open Etanercept in the interactive console ↗